Midatech Pharma Plc Institutional ownership
What is the Institutional ownership of Midatech Pharma Plc?
The Institutional ownership of Midatech Pharma Plc is 12.68%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on LSE compared to Midatech Pharma Plc
What does Midatech Pharma Plc do?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Companies with institutional ownership similar to Midatech Pharma Plc
- Greif Bros has Institutional ownership of 12.66%
- Mobivity has Institutional ownership of 12.67%
- Future Retail has Institutional ownership of 12.67%
- Gladstone Capital has Institutional ownership of 12.67%
- Hi Crush Inc has Institutional ownership of 12.67%
- Hi-Crush has Institutional ownership of 12.67%
- Midatech Pharma Plc has Institutional ownership of 12.68%
- Great Eagle has Institutional ownership of 12.68%
- Assure has Institutional ownership of 12.68%
- Novonix has Institutional ownership of 12.68%
- Novonix has Institutional ownership of 12.68%
- DiDi Global Inc has Institutional ownership of 12.68%
- American Pacific Borates has Institutional ownership of 12.69%